The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
Open accessAbstract
A nonsynonymous single-nucleotide polymorphism at codon 47 in TP53 exists in African-descent populations (P47S, rs1800371; referred to here as S47). Here we report that, in human cell lines and a mouse model, the S47 variant exhibits a modest decrease in apoptosis in response to most genotoxic stresses compared with wild-type p53 but exhibits a significant defect in cell death induced by cisplatin. We show that, compared with wild-type p53, S47 has nearly indistinguishable transcriptional function but shows impaired ability to transactivate a subset of p53 target genes, including two involved in metabolism: Gls2 (glutaminase 2) and Sco2. We also show that human and mouse cells expressing the S47 variant are markedly resistant to cell death by agents that induce ferroptosis (iron-mediated nonapoptotic cell death). We show that mice expressing S47 in homozygous or heterozygous form are susceptible to spontaneous cancers of diverse histological types. Our data suggest that the S47 variant may contribute to increased cancer risk in individuals of African descent, and our findings highlight the need to assess the contribution of this variant to cancer risk in these populations. These data also confirm the potential relevance of metabolism and ferroptosis to tumor suppression by p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citationRegulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“The majority of these is missense mutations that occur in theDNA-binding domain, which inhibit the ability of this protein to bind to p53 response elements in the promoters of p53 target genes and subsequently transactivate gene expression (Vogelstein et al. 2000).”
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 9×
“p53 is required for erastin-mediated ferroptosis, in part due to the ability of this protein to bind and negatively regulate the promoter for the cystine transporter SLC7A11 (Jiang et al. 2015).”
InfluentialBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 4×
“In addition, the p53 target gene GLS2 and the process of glutaminolysis have recently been implicated in ferroptosis (Gao et al. 2015).”
InfluentialOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · cited 1×
“Mouse models for Li-Fraumeni syndrome, which contain DNA-binding domain mutants of p53, frequently develop lymphoma and sarcoma but also develop cancers of epithelial origin (Lang et al. 2004).”
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., Rebsamen, M., Superti-Furga, G., & Stockwell, B. R. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00245 · Cited by 1,043 · cited 1×
“…of ferroptosis has been implicated in tumor suppression by p53; ferroptosis is an iron-mediated nonapoptotic cell death pathway that requires high reactive oxygen species and likely involves a lipid peroxide intermediate (Dixon et al. 2012, 2015; Dix-on and Stockwell 2014; Yang et al. 2014).”
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
Bulavin, D. V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6845 · Cited by 711
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis
D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., et al. (2002) · Nature Cell Biology · doi:10.1038/ncb714 · Cited by 681
Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
Hofmann, T. G., Möller, A., Sirma, H., Zentgraf, H., Taya, Y., Dröge, W., Will, H., & Schmitz, M. L. (2002) · Nature Cell Biology · doi:10.1038/ncb715 · Cited by 592
Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
Brady, C. A., Jiang, D., Mello, S. S., Johnson, T. M., Jarvis, L. A., Kozak, M. M., Broz, D. K., Basak, S., Park, E. J., McLaughlin, M. E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.035 · Cited by 533
Kenzelmann Broz, D., Spano Mello, S., Bieging, K. T., Jiang, D., Dusek, R. L., Brady, C. A., Sidow, A., & Attardi, L. D. (2013) · Genes & Development · doi:10.1101/gad.212282.112 · Cited by 443 · cited 2×
“For Gls2 , we identified two consensus p53-binding sites in the murine gene — one in the promoter that overlapped the transcriptional start site and another that was nearly 75 kb upstream of the promoter; both of these sites had significant p53 ChIP-seq (ChIP combined with deep sequencing) peaks in published data sets…”
Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 379
Taira, N., Nihira, K., Yamaguchi, T., Miki, Y., & Yoshida, K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.007 · Cited by 295
Li, M., He, Y., Dubois, W., Wu, X., Shi, J., & Huang, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.020 · Cited by 264
Polymorphisms in the p53 pathway
Pietsch, E. C., Humbey, O., & Murphy, M. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209367 · Cited by 237
Self-citationSnapShot: p53 Posttranslational Modifications
Kruse, J.-P., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.05.020 · Cited by 170
Role of the p38 MAPK pathway in cisplatin-based therapy
Losa, J. H., Cobo, C. P., Viniegra, J. G., Lobo, V. J. S.-A., Cajal, S. R. Y., & Sánchez-Prieto, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206608 · Cited by 166
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157
Ser46 Phosphorylation Regulates p53-Dependent Apoptosis and Replicative Senescence
Feng, L., Hollstein, M., & Xu, Y. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3526 · Cited by 140
Self-citationLuo, J., Yang, Q., Tong, W., Hergenhahn, M., Wang, Z., & Hollstein, M. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204080 · Cited by 135
Self-citationThe Codon 47 Polymorphism in p53 Is Functionally Significant
Li, X., Dumont, P., Pietra, A. D., Shetler, C. M., & Murphy, M. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414637200 · Cited by 134
Self-citationFrank, A. K., Leu, J. I.-J., Zhou, Y., Devarajan, K., Nedelko, T., Klein–Szanto, A. J., Hollstein, M. C., & Murphy, M. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01136-10 · Cited by 117
Self-citationSingle-nucleotide Polymorphisms in the p53 Signaling Pathway
Grochola, L. F., Zeron-Medina, J., Meriaux, S., & Bond, G. L. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001032 · Cited by 113
Pin1-Induced Proline Isomerization in Cytosolic p53 Mediates BAX Activation and Apoptosis
Follis, A. V., Llambi, F., Merritt, P., Chipuk, J. E., Green, D. R., & Kriwacki, R. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.029 · Cited by 108
Liu, J., Zhang, C., Lin, M., Zhu, W. J., Liang, Y., Hong, X., Zhao, Y., Young, K. H., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.1862 · Cited by 108
Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.
Felley‐Bosco, E., Weston, A., Cawley, H., Bennett, W. P., & Harris, C. C. (1993) · Europe PMC (PubMed Central) · Cited by 104
Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
Sprowl, J. A., Lancaster, C. S., Pabla, N., Hermann, E., Kosloske, A. M., Gibson, A. A., Li, L., Zeeh, D., Schlatter, E., Janke, L. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0319 · Cited by 83
Su, D., Wang, X., Campbell, M. R., Song, L., Safi, A., Crawford, G. E., & Bell, D. A. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004885 · Cited by 65
Self-citationThe ARF Tumor Suppressor Can Promote the Progression of Some Tumors
Humbey, O., Pimkina, J. S., Zilfou, J. T., Jarník, M., Dominguez‐Brauer, C., Burgess, D. J., Eischen, C. M., & Murphy, M. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2263 · Cited by 53
Self-citationNoureddine, M., Menéndez, D., Campbell, M. R., Bandele, O. J., Horvath, M. M., Wang, X., Pittman, G. S., Chorley, B. N., Resnick, M. A., & Bell, D. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000462 · Cited by 51
Self-citationCommon tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72
Reinbold, M., Luo, J.-L., Nedelko, T., Jerchow, B., Murphy, M. E., Whibley, C. E., Wei, Q., & Hollstein, M. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210932 · Cited by 43
Self-citationCisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitryPreprint
Zhu, Y. Y., Regunath, K., Jacq, X., & Prives, C. L. (2013) · Genes & Development · doi:10.1101/gad.212258.112 · Cited by 39
Bandele, O. J., Wang, X., Campbell, M. R., Pittman, G. S., & Bell, D. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq764 · Cited by 35
Self-citationGenome-wide analysis of the p53 gene regulatory network in the developing mouse kidney
Li, Y., Liu, J., McLaughlin, N., Bachvarov, D. R., Saifudeen, Z. R., & El-Dahr, S. S. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00113.2013 · Cited by 18
Cited by
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Self-citationFerroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Stockwell, B. R. (2022) · Cell · doi:10.1016/j.cell.2022.06.003 · Cited by 3,056
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Metadata
- Authors
- Jennis, M., Kung, C.-P., Basu, S., Budina-Kolomets, A., Leu, J. I.-J., Khaku, S., Scott, J. P., Cai, K. Q., Campbell, M. R., Porter, D. K., Wang, X., Bell, D. A., Li, X., Garlick, D. S., Liu, Q., Hollstein, M., George, D. L., & Murphy, M. E.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-03-31
- Volume
- 30
- Issue
- 8
- Pages
- 918-930
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2327775625
- Cited by
- 352
- References
- 41
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.